Thrive Rx is a clinician-led telehealth longevity program: AHPRA-registered practitioners, tiered pathology from Detect ($1,248/year) to Optimise ($2,848/year), and ongoing consults over 6 to 12 months. It is one of Australia's most structured proactive care pathways.
If you want comprehensive pathology and a living blood record without a $1,248+ telehealth program, Hemexa is AU$799/year all-in: GP-reviewed requests, Laverty collection nationwide, up to 60+ signature markers on your baseline (a small number are sex-specific), an included six-month retest, a health-system dashboard, self-serve pathology PDF imports, and supplement insights tied to your blood results.
Your annual baseline includes 60+ signature markers (exact count depends on sex; typically 59–63 measured). Fast-moving markers are tested again on your included six-month retest.
Join the Hemexa founding waitlist
Thrive Rx pairs tiered pathology with AHPRA telehealth clinicians, structured reviews at 12 weeks and ongoing, and optional medications or peptides where clinically appropriate (billed separately at pharmacy retail with no markup). Prescriptions are never guaranteed; it is not a script service.
Hemexa is for Australians who want platform-led blood intelligence: upload your own pathology PDFs, see health-system scores and trends, and get supplement insights linked to your markers, without stepping into a consult-heavy care plan or separate medication billing.
Thrive Rx is built for Australians who want a regulated, AHPRA-led longevity pathway: structured consults, tiered pathology, and optional prescribing over 6 to 12 months. Hemexa is built for Australians who want comprehensive pathology and a living blood record at a lower annual price, without stepping into a consult-heavy telehealth program.
Thrive Rx memberships start at $1,248/year (Detect) with telehealth consults, clinical reviews, and a 6 to 12-month care plan. Hemexa is $799/year all-in for baseline, six-month retest, dashboard, plan, and supplement insights tied to your markers.
Thrive Rx pairs pathology with AHPRA clinician oversight, protocols, and medications or peptides where clinically appropriate (billed separately at pharmacy retail). Hemexa focuses on blood intelligence: health-system scores, trends, and a plan after every panel without prescribing upsells.
Thrive Rx clinicians can review recent pathology at intake, but specialised longevity panels included in your membership are still required. Hemexa lets you upload pathology PDFs yourself after your first baseline, so older results sit in your timeline on your terms.
Thrive Rx is strong on regulated telehealth longevity care and structured clinical partnership. Hemexa is built for members who want to own their blood timeline: upload PDFs yourself, track health-system scores, and see supplement guidance tied to your actual marker results after each panel.
Thrive Rx clinicians review recent pathology at intake where relevant, but membership panels are still required and older results are not self-serve imports into a member-owned timeline. Hemexa lets you add pathology PDFs directly after your baseline.
Thrive Rx excels at regulated telehealth longevity care with tiered pathology and optional medications where clinically appropriate. Hemexa focuses on what your blood shows over time: health-system scores, trends, a personalised plan, and supplement guidance at one membership price.
Hemexa includes 60+ signature markers on your baseline and an included six-month retest at AU$799/year all-in. Thrive Rx Detect starts at $1,248/year with 30+ core markers; Optimise reaches 60+ comprehensive markers at $2,848/year.
After your first Hemexa panel, upload PDFs from other Australian pathology providers yourself. Thrive Rx can review recent results at intake, but specialised longevity panels are still required and past results are not a self-serve timeline import.
Log your stack and get platform insights connected to your marker results after each panel. Thrive Rx addresses supplements through clinician protocols and optional prescribing; Hemexa ties them directly to your dashboard signals.
Hemexa is built for comprehensive blood tracking at one annual price. If you want AHPRA clinician partnership, structured consults, and a prescribing pathway, Thrive Rx is worth comparing. If you want pathology depth and a living blood record, Hemexa is the fit.
A side-by-side for Australians comparing Thrive Rx with other options. Look past tiered pathology: how you bring in past results, how supplements connect to your blood, and whether you want a clinician-led care plan or an all-in blood intelligence membership.
| Feature | Thrive Rx | Vively | Everlab | Function Health | Hemexa |
|---|---|---|---|---|---|
| Available in Australia | Yes | Yes | Yes (select states for full program) | No (US only) | Yes |
| Annual membership (from) | From $1,248/yr (Detect) | From $99 baseline + app | $799/yr (Essentials) | ~US$499/yr | $799/yr all-in |
| Signature biomarkers (entry tier) | 30+ (Detect); up to 60+ (Optimise) | 60+ baseline | 65+ (Essentials); 90+ on Advanced Bloods | 100+ (US panel) | 60+ signature markers |
| Six-month retest included | Yes (2 panels/year) | Varies by membership | Yes (twice yearly on Essentials) | Yes (US members) | Yes, included |
| Australian pathology network | Partner laboratories | 4,000+ collection centres | 1,850+ partner labs | Quest (US only) | Laverty nationwide |
| Clinical review of results | AHPRA telehealth clinicians | Practitioner review in app | Longevity doctor review | US clinician workflow | GP-reviewed test requests |
| Health-system dashboard | Yes (platform) | Yes (app) | Yes (10+ category scores) | Results-focused | Systems, scores, and trends |
| Personalised health plan | Clinician protocols | Yes | Yes (doctor-led) | Summary-style | Yes, after every panel |
| Bring in past pathology from other labs | Intake review; own panels required | No | Concierge (team requests records) | No | Self-serve PDF upload |
| Blood-linked supplement insights | Clinician protocols (+ prescribing) | Limited | Doctor-led in intervention plans | Listed at signup | Yes, tied to your markers |
| Prescribing / peptides | Yes, where clinically appropriate (meds extra) | Not the focus | Varies by program | Limited | Blood-first; not a prescribing service |
| Primary model | Clinician-led telehealth care | CGM + metabolic baseline | Premium longevity clinic | US subscription panel | AU biomarker membership |
Competitor pricing and inclusions change. Confirm current details on each provider website before you decide.
Thrive Rx excels at clinician-led longevity care. Hemexa is AU$799/year all-in for Australians who want comprehensive pathology, imports, and a living record without telehealth consult upsells.
Join the Hemexa founding waitlist
No provider is right for everyone. Choose based on what you actually want from your next blood test or membership, then join Hemexa if the wedge fits.
Join the Hemexa founding waitlist
Hemexa is a preventative health membership and health intelligence platform. It does not provide medical advice, diagnosis, treatment, or emergency care. Always discuss results and health decisions with your GP or qualified clinician. Read our health disclaimer.
Claim a founding spot and we will send next steps when onboarding opens. Or browse all 60+ signature markers before you decide.
Join the Hemexa founding waitlist
